Literature DB >> 29180019

Overcoming challenges for amplified expression of recombinant proteins using Escherichia coli.

Irshad Ahmad1, Nighat Nawaz2, Nizam M Darwesh3, Sadeeq Ur Rahman4, Mohammad Z Mustafa5, Sher B Khan6, Simon G Patching7.   

Abstract

A thorough characterisation of the genetics, physiology and metabolism of Escherichia coli has led to the availability of a large number of strains and vectors suitable for recombinant protein expression. Despite the relative ease in using E. coli for achieving amplified expression of many recombinant proteins, for some proteins this can be a frustrating and time-consuming process leading to very low expression or no expression at all. This is especially true for membrane proteins, which introduce additional challenges. A number of factors can be considered and optimised for achieving required levels of amplified expression of recombinant proteins in E. coli that are broadly classified as host strain, expression vector and growth conditions. In this paper we summarise these factors and consolidate the common challenges encountered and approaches to overcome them, focusing in particular on cases where there is low amplified expression or no expression at all of the desired recombinant protein, due to various reasons.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Bacteria; E. coli; Membrane proteins; Protein expression; Recombinant proteins

Mesh:

Substances:

Year:  2017        PMID: 29180019     DOI: 10.1016/j.pep.2017.11.005

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  7 in total

1.  Harnessing synthetic biology to enhance heterologous protein expression.

Authors:  Shlomo Zarzhitsky; Alex Jiang; Elizabeth E Stanley; Michael H Hecht
Journal:  Protein Sci       Date:  2020-07-13       Impact factor: 6.725

2.  Expression optimization of recombinant cholesterol oxidase in Escherichia coli and its purification and characterization.

Authors:  Aliakbar Fazaeli; Abolfazl Golestani; Mostafa Lakzaei; Samaneh Sadat Rasi Varaei; Mahdi Aminian
Journal:  AMB Express       Date:  2018-11-12       Impact factor: 3.298

3.  Reactivity of human antisera to codon optimized SARS-CoV2 viral proteins expressed in Escherichia coli.

Authors:  Yee-Huan Toh; Yu-Weng Huang; Yo-Chen Chang; Yi-Ting Chen; Ya-Ting Hsu; Guang-Huey Lin
Journal:  Tzu Chi Med J       Date:  2021-03-09

4.  Engineering of a new Escherichia coli strain efficiently metabolizing cellobiose with promising perspectives for plant biomass-based application design.

Authors:  Romain Borne; Nicolas Vita; Nathalie Franche; Chantal Tardif; Stéphanie Perret; Henri-Pierre Fierobe
Journal:  Metab Eng Commun       Date:  2020-12-19

5.  Expression of full and fragment-B of diphtheria toxin genes in Escherichia coli for generating of recombinant diphtheria vaccines.

Authors:  Shaimaa Abulmagd; Abd El-Nasser A Khattab; Hamdallah Zedan
Journal:  Clin Exp Vaccine Res       Date:  2022-01-31

6.  In silico designing of a recombinant multi-epitope antigen for leprosy diagnosis.

Authors:  Marcela Rezende Lemes; Thaís Cristina Vilela Rodrigues; Arun Kumar Jaiswal; Sandeep Tiwari; Helioswilton Sales-Campos; Leonardo Eurípedes Andrade-Silva; Carlo Jose Freire Oliveira; Vasco Azevedo; Virmondes Rodrigues; Siomar C Soares; Marcos Vinicius da Silva
Journal:  J Genet Eng Biotechnol       Date:  2022-09-02

Review 7.  Protein PEGylation: Navigating Recombinant Protein Stability, Aggregation, and Bioactivity.

Authors:  Lindiwe Khumbuzile Zuma; Nothando Lovedale Gasa; Xolani Henry Makhoba; Ofentse Jacob Pooe
Journal:  Biomed Res Int       Date:  2022-07-25       Impact factor: 3.246

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.